The Truth About Skin Care

In a landmark decision, the Centers for Medicare & Medicaid Services (CMS) has announced it will now cover the use of FDA-approved dermal fillers for the treatment of HIV-associated facial lipoatrophy (LA), severely hollowed cheeks and changes to the face’s appearance resulting from HIV treatments…

Suneva Medical, a privately-held aesthetic medical device company, announced that two clinical studies suggest Artefill may be a safe, effective, long-term treatment option for age-related and HIV lipoatrophy patients…

A class of antibiotics known as aminoglycosides could be used to make a topical cream that would trigger production of a protein in humans to prevent HIV transmission, according to a study published Tuesday in PLoS Biology, the Orlando Sentinel reports.

A Canadian prison tattoo parlor program that was canceled by the government was cost-effective and successful in raising awareness and reducing the risk of bloodborne diseases such as HIV and hepatitis C, according to a new report from the Correctional Service of Canada, the Alberta Daily Herald-Tribune reports.

The HTA (Human Tissue Authority) is announcing new rules for bone and skin products to protect patients from diseases such as HIV, Hepatitis C and CJD. The HTA already regulates the use of tissue containing cells to treat patients. The new rules will apply to material from humans that does not contain any cells.